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Background: For decades, the discussion on children’s competence to consent to medical issues has concentrated
around normative concerns, with little progress in clinical practices. Decision-making competence is an important
condition in the informed consent model. In pediatrics, clinicians need to strike a proper balance in order to both
protect children’s interests when they are not fully able to do so themselves and to respect their autonomy when
they are. Children’s competence to consent, however, is currently not assessed in a standardized way. Moreover,
the correlation between competence to give informed consent and age in children has never been systematically
investigated, nor do we know which factors exactly contribute to children’s competence.
This article aims at identifying these gaps in knowledge and suggests options for dealing with the obstacles in
empirical research in order to advance policies and practices regarding children’s medical decision-making
competence.
Discussion: Understanding children’s competency is hampered by the law. Legislative regulations concerning
competency are established on a strong presumption that persons older than a certain age are competent,
whereas younger persons are not. Furthermore, a number of contextual factors are believed to be of influence on a
child’s decision-making competence: the developmental stage of children, the influence of parents and peers, the
quality of information provision, life experience, the type of medical decision, and so on. Ostensibly, these diverse
and extensive barriers hinder any form of advancement in this conflicted area. Addressing these obstacles encourages
the discussion on children’s competency, in which the most prominent question concerns the lack of a clear
operationalization of children’s competence to consent. Empirical data are needed to substantiate the discussion.
Summary: The empirical approach offers an opportunity to give direction to the debate. Recommendations for
future research include: studying a standardized assessment instrument covering all four relevant dimensions of
competence (understanding, reasoning, appreciation, expressing a choice), including a study population of
children covering the full age range of 7 to 18 years, improving information provision, and assessing relevant
contextual data.
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The informed consent model assigns patients autonomy
over medical interventions, including self-determination,
with regard to their body, health, private life and some-
times even death. Exercising this autonomy regularly
imposes a considerable burden of responsibility on the
patient. However, where children and adolescents are
concerned, we do not know if they are able to decide on* Correspondence: i.hein@debascule.com
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unless otherwise stated.medical issues in a meaningful way. There is no con-
sensus on when they are competent to consent to treat-
ment or clinical research.
Competence, as used it in this article, is the clinical
concept of the ability of a person to consent to medical
interventions or clinical research. Strictly speaking, in-
competence denotes a legal status that in principle
should be determined by a court. In clinical practice
competence is generally addressed as decision-making
capacity [1]. In this article we use the terms competence
and decision-making capacity interchangeably, unless
otherwise specified we are referring to the clinicalis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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accepted reference standard for competence assessment
by clinicians revolves around four relevant criteria: to
communicate a choice, to understand the relevant infor-
mation, to appreciate the medical consequences of the
situation, and to reason about treatment choices [2].
We are interested in children’s competence to consent
in both the treatment context and the clinical research
context, although these two may not be the same.
Although laws differ between nations and states, most
laws prescribe that children and adolescents, hereinafter
referred to as children, can exercise their rights as a
patient from a certain age, including the right to give
informed consent. However, these age limits vary con-
siderably between countries and states.
Within the context of daily pediatric practice, compe-
tence is usually assessed implicitly. However, competency
can become problematic when concerns rise about the
capacities of pediatric patients to make well-considered
decisions. For example, in some countries, when a 12-year
old boy with acute leukemia is asked to participate in a
drug trial, the researcher has the authority to judge the
boy competent and his decision to consent to research
participation valid or invalid. Or, in the case of a 15-year
old girl with anorexia nervosa who, against her parents’
wishes, refuses to be tube fed, the treating pediatrician
could be tasked with judging whether the girl is com-
petent to refuse the proposed treatment. Again, this all
depends on the local laws and regulations of the countries
in which these cases occur.
For clinicians it is vital to strike a proper balance be-
tween protecting children’s interests when they are un-
able to do so themselves, and respecting their autonomy
when they are. Since law is established on a strong pre-
sumption that persons older than a certain age are com-
petent, whereas younger persons are not, it is decisive
that a fixed age-limit for alleged competence is generally
in accordance with children’s developmental stages.
Furthermore, for pediatric patients and parents, availa-
bility of a reliable standard for assessing competence is
important.
Children’s competence to consent, however, is currently
not assessed in a standardized way. Moreover, neither the
correlation between competence to give informed consent
and age in children, nor which factors exactly contribute
to children’s competence, have ever been systematically
researched.
Former discussion on children’s competence to con-
sent to medical issues has consistently been focused on
normative concerns, which has impeded progress in
clinical practices. The aim of this article is to offer rec-
ommendations for finding a way out of the impasse by
means of identifying the gaps in knowledge about chil-
dren’s competence issues and by suggesting options fordealing with the obstacles in empirical research. Empir-
ical research outcomes are needed to make recom-
mendations for optimizing policies, in order to do
justice to the capacities and challenges children face




History shows different perspectives on dealing with
children’s competence issues. The enormity of the abuse
in human experimentation in World War II led to
the emergence of patients’ rights in medical decision-
making [3]. In the ensuing years, competency issues
involving children in clinical research proved espe-
cially problematic. The possibility of exposing children
to the risk of harm was an ever present concern. But
excluding them from research was not an option as
biomedical research did prove successful: many exam-
ples showed that the mortality rate in children was
drastically reduced [3]. To ensure research participa-
tion of children, while warranting their safety, specific
pediatric regulations and guidelines were put in place.
Nevertheless, until the nineties children kept being
excluded from trials just to safeguard their vulnerability
[4]. Developments regarding children’s competence in the
treatment setting currently show that autonomous rights
to self-determination have been extended and are now
more variably assigned than before [5].
In law, competence has traditionally been associated
with age [6]. Generally the law presumes that certain
persons (i.e., adults) are competent, whereas others (chil-
dren) are not. The statutory age of majority is commonly
set at 18 years, although there are exceptions to this
rule. Normally, young children under the age of 12 have
no formal right to be involved in the informed consent
process with their parents [7]. Differences exist between
states and countries regarding the age at which children
are deemed able to make competent decisions. In
Europe, domestic law determines whether or not people
are competent to consent to healthcare interventions
[8]. In some countries autonomous decision-making is
deemed legal at age 18, while in other countries minors
are allowed to take healthcare decisions from a fixed age
below legal majority, e.g., 14 years in Portugal and
15 years in Denmark [8]. A more flexible system exists
in most Canadian provinces and Switzerland where the
competence of children to consent is evaluated on a
case-by-case basis [8]. In the United States statutes
often specify various minimum ages (usually 12, 14, or
16 years) for independent consent by children for specific
types of treatment [9]. In the United States regulations for
clinical research state that some children under the age
of 18 might be able to give their assent, meaning an
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may still waive the assent requirement [10].
Obviously there is no international consensus on the
exact age limit for presuming competence to consent in
children [11]. To some extent, age limits seem arbitrary
and ineffective as there are individuals above the limit
who are deemed incompetent and individuals below the
limit who are deemed competent. Though age limits are
practicable, they may only serve their goal if they are
generally in accordance. While statutory age limits have
obviously taken into consideration the welfare of both
society and the child, there is no clear empirical evidence
regarding the competence of children’s age groups.
Developmental aspects
Elementary school children face cognitive limitations; they
lack the broad-based knowledge adults possess and some-
times have trouble applying their cognitive skills to a lar-
ger problem-solving process. They may view the world in
concrete terms and cannot reason maturely about abstract
and hypothetical problems [3,12]. In adolescence, bio-
logical, cognitive, and social development progress and
the brain undergoes substantial change with an increase
in efficiency of brain functioning. New cognitive skills are
acquired, referred to by Piaget as hypothetico-deductive
reasoning: the ability to think of hypothetical solutions
and to formulate a systematic plan for deducing which of
these solutions is correct [12,13]. Social-cognitive changes
lead to increased maturity in reasoning about moral issues
as well [14]. In middle adolescence (15 to 17) a strong
development in metacognitive understanding emerges, in-
cluding knowledge of one's own qualities, characteristics,
and limitations with regard to decision-making [15]. Even
with these advances, certain cognitive limitations remain,
mostly involving inconsistent application of recently ac-
quired cognitive abilities. Differences in decision-making
between adolescents and adults have been found in the
ability to act or think responsible, the ability to restrain
impulsiveness, and the ability to place a given decision in
a larger temporal context [16]. Data suggest that the ado-
lescent brain still differs significantly from the adult brain,
not least because the frontal lobes that are essential for
effective executive functions mature later in children than
they do in adults [17]. Adolescents generally do not fully
possess the capacity to appreciate the long-term conse-
quences of their choices until the age of 21 [17].
Apart from cognitive abilities, competence in children
is thought to be related to life experience: children who
have personal experiences with illness may show greater
insight and understanding than children of comparable
age who lack this experience [11,18,19].
Furthermore, as children grow up they are, to a greater
extent than adults, dependent on other people, especially
their caretakers or parents [12,14,20]. Children may bemore obedient to parents and healthcare professionals
because of their need for approval or fear of rebuke from
authority figures [6,9,14,21]. It is postulated that the
quality of the relationship between the parent and the
child and the doctor and patient is highly influential
on the child’s ability to make well-informed decisions
[22]. An authoritative parenting style which includes
direction-giving and limit-setting is positively correlated
with an adolescent’s developing capacity for autonomous
decision-making [17]. Various authors argue that early
adolescents (10 to 14) are more susceptible to peer influ-
ences than at any other age [16], which may hinder their
ability to make thoughtful decisions [15].
Empirical data
Extensive empirical research data on children’s decision-
making competence are lacking. So far, only two studies
on children’s competence to consent that comprised all
four criteria have been conducted. Turrell and col-
leagues, using MacArthur Competence Assessment
Tool for Treatment (MacCAT-T), conducted a com-
parative study on competence to consent in adolescents
with anorexia nervosa and in adolescents considered
healthy (in medicine known as healthy controls); that is,
uncompromised by any disorders or illness, and found
group differences: adolescents with anorexia nervosa
tend to experience more problems in reasoning about
treatment than healthy controls [23]. Koelch and collea-
gues examined the MacArthur Competence Assessment
Tool for Clinical Research (MacCAT-CR) on a small
sample of children and adolescents aged 7 to 12 diagnosed
with Attention Deficit Hyperactivity Disorder and con-
cluded that the tool was feasible and offered a detailed
assessment, recommending further research on the valid-
ity of the tool [24]. Other studies directed at assessing
children’s competence in medical decision-making vary
widely; while often making use of both hypothetical and
actual decision-making scenarios, these studies mostly
measure only one dimension of competence, disregarding
validity and reliability altogether [21].
Practical barriers
Some authors consider the limited application of compe-
tence assessment in research a direct result from the lack
of an operationalization of children’s decision-making
competence [21]. Well-elaborated checklists that offer
guidelines for good practice do exist [7,19]; however, the
last one was written half a decade ago and systematic
research data to underpin these guidelines are not avail-
able. Reliability of a standard for assessing competence is
important for health care professionals as well as pediatric
patients and parents.
There is no consensus on which age spans to study,
due to differences in local regulations. Decision-making
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may concern: complex medical situations in exceptional
cases, and more routine-like medical situations in the
general pediatric population. However, it is not yet es-
tablished how to incorporate the varying levels of risk
and complexity of the decision into the assessment. One
possible way to deal with the issue is to require a higher
level of competence to consent for a decision with a
higher potential risk and to require a higher level of
competence to refuse for a decision with higher benefit
[19]. Nevertheless, the level of risk is not yet well defined
or quantifiable [11,14].
Furthermore, it has been stated that consent to partici-
pation in research must be a more stringent process
than consent to treatment, not necessarily because of
higher levels of risk but because the research partici-
pants are asked to help improve general health care and
thus do not profit individually [25]. However, there are
no data yet to justify the supposed differences between
children’s competence in the research and treatment
context.
In addition, the discussion is ongoing on the dichotom-
ous versus dimensional model of competence assessment.
Buchanan and Brock [26] state that decision-making cap-
acity is a matter of minor differences (gradual model) and
competence is either present or not (threshold model).
The gradual model may be more consistent with pediatric
clinical practice, although a particular situation often
requires a definitive assessment of competence. Some
assessment instruments define decision-making capacity
as the sum of different abilities, although we do not know
whether these can be added up, or whether a threshold
can be based on statistical arguments [27].
Besides, children’s competence relies on optimal infor-
mation provision that enhances their understanding.
Techniques for improving this include using clearly
worded information tailored to their comprehension
level. Decision-making can be facilitated by breaking the
process down into smaller but linked choices. Commu-
nication difficulties can be overcome by innovative and
age-appropriate techniques to convey information [12,19].
When assessing children’s competence to consent, the
quality and relevance of information must be optimized.
Although the need to evaluate competence to consent
to treatment and clinical research has gained increasing
attention, no consensus has been reached on how to
assess it. The current situation has been referred to as a
“hodgepodge of practices” [28]: there is no gold standard
and no hard empirical data [14]. In the last two decades
numerous tools have been developed to assess compe-
tence in adults. To name but a few: the Competency
Questionnaire, the Hopkins Competency Assessment
Test, the MacCAT-T and MacCAT-CR and the Structured
Interview for Competency and Assessment Testing andRanking Inventory [28]. Of all these, the MacCAT tools
have ranked the highest and are considered the best
choice for measuring capacity to consent to treatment and
clinical research in adults [28]. Nonetheless, assessing
competence to consent in children, even with adequate
tools such as the MacCAT, is still lacking. As de-
scribed above, only one study confirmed feasibility of
the MacCAT-CR in children [24] and MacCAT-T has
only been applied in adolescents [23].
Directions
Clinical research on children’s competence to consent so
far has been hampered by the absence of a guiding
theory or framework with which to formulate hypotheses
and interpret results. In discussions, a consensus defin-
ition of the clinical concept of children’s competence may
be unreachable when taking into consideration the many
questions under debate. Therefore setting out a research
agenda regarding children’s competence to consent has
not yet been accomplished.
For professionals it might be more profitable to find
an approach in empirical research than to be entangled
in substantial theoretical debate with no solution in
sight. In adults, systematic studies using MacCAT-CR
were conducted in populations of mentally compromised
patients [29,30]. Although the researchers faced compar-
able problems as described above, the research results
contributed to further establishment of reliability and
validity of a standardized competence assessment tool.
Furthermore, results offered insight into the compe-
tencies of a given population regarding a given medical
decision. Although the complexity of the clinical concept
of children’s competence implies that competence assess-
ment methods proposed by clinical researchers should not
be expected to do full justice to all legal and ethical facets,
still standardized methods are indispensable and can
enhance insight into the clinical concept of children’s
competence.
Experience from the small amount of research on
children’s and adults’ competence to consent so far per-
mits several recommendations for addressing the di-
lemmas in future research. Absent a standard, a clear
definition and operationalization of children’s compe-
tence is needed. For this, consulting adult literature can
be a starting point. The range of abilities to be studied
must include the four relevant criteria which, to our
knowledge, cover the basic aspects of assessment: un-
derstanding, appreciation, reasoning and expressing a
choice [31]. Previous research demonstrated that the
MacCAT scales provide the best results [28-30]. Imple-
menting such a structured multidimensional tool would
make it possible to systematically assess the different
dimensions of competence [32] and make outcomes
comparable [21].
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tence assessment studies. Observational methods (video-
taping or direct observation) can help us gain more
insight into the decision-making process in children and
identify aspects of the communication that facilitate
decision-making [21,33]. Actual decision-making, instead
of hypothetical decision-making, may better reflect the
way children and parents behave in real-world settings.
More ethnical diversity in research samples is needed in
order to increase generalizibility [21].
As children’s competence is likely to reflect a dynamic
construct, it is important that the research design allows
for these changes to be measured. The decision-making
context for treatment and research is fundamentally
different in many ways, but it is not clear if research and
treatment situations elicit similar or different decision-
making processes. Findings from studies that examine
research decisions may not be generalizable to treatment
decisions and may need different assessment methods,
but the situations should be compared regardless.
Next to the legal requirements for competence that
emphasize cognitive components such as understanding
and reasoning ability, other important contextual vari-
ables that may influence children’s competence have not
been very visible in research on competence so far and
need more attention. The dependence of children on
parents and caretakers [12,14,20] and the shift of parent
orientation to peer orientation in adolescence [34] should
be assessed.
The appropriate age span to be studied should cover
ages at both the lower end as well as at the upper
end of varying statutes and jurisdictions, leading to a
study population of children from 7 to 18 years of age.
Different types of medical decisions must be studied in
order to obtain data covering high risk, low risk, high com-
plex, and low complex decisions. Although the level of risk
and complexity are currently not quantifiable [11,14], em-
pirical research seems the most effective way to gather data
and evaluate the relative contribution of these factors.
Considering that children’s personal experiences with
illness might enhance their competence to consent
[11,18,19,21], there is good reason to assess the duration
of the illness and the experience of the child with the
healthcare system.
Two studies suggested a positive relationship between
intelligence and competence, as measured by the Wechsler
Intelligence Scale for Children [21]. Because cognitive
capacities may play an important role in decision-
making competence, assessment by an intelligence test
should be included.
Summary
The discussion on children’s competence to consent
to treatment and clinical research has made littleadvancement the last decade. The ongoing debate in-
volves many normative and developmental aspects and
has not yielded progress in practical implementation.
The empirical approach offers an opportunity to give
direction to the debate and may lead to a clear research
agenda.
Recommendations for future research include: study-
ing a standardized assessment instrument covering all
four relevant dimensions of competence; including a
study population of children covering the full age range
of 7 to 18 years; improving information provision; and
assessing relevant contextual data. Research data are
needed to underpin theories and guidelines and advance
regulations concerning children’s decision-making com-
petence in the medical context.
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